Comparison of Dendritic Cells Versus Montanide as Adjuvants in a Melanoma Vaccine

NCT00124124 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

50

Enrollment

INDIV

Sponsor class

Conditions

Melanoma

Interventions

DRUG: KLH; Peptides; Dendritic Cells
DRUG: KLH, peptides plus Montanide

Sponsor

Dr. Nina Bhardwaj

Collaborators

[object Object]